Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2019-10-31 2020-09-24 97625
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2023-06-08 2023-07-06 194119
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2023-06-16 2023-08-04 195033
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2023-06-19 2023-07-14 195597
TEVA-IRBESARTAN HCTZ 12.5MG 300MG TABLET Resolved 2017-05-10 2017-09-19 9785
TEVA-IRBESARTAN HCTZ 12.5MG 300MG TABLET Resolved 2018-03-13 2018-05-30 42582
TEVA-IRBESARTAN HCTZ 12.5MG 300MG TABLET Resolved 2018-12-04 2019-04-11 68622
TEVA-IRBESARTAN HCTZ 12.5MG 300MG TABLET Resolved 2019-12-05 2021-09-10 100305
TEVA-VALSARTAN/HCTZ 12.5MG 320MG TABLET Resolved 2017-04-25 2018-02-21 8074
TEVA-VALSARTAN/HCTZ 12.5MG 320MG TABLET Actual shortage 2018-10-23 2019-07-15 65369
TEVA-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Resolved 2017-03-13 2017-10-10 974
TEVA-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Resolved 2019-11-28 2020-04-23 99932
TEVA-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Resolved 2022-10-28 2022-12-15 173031
TEVA-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Resolved 2023-10-05 2024-04-05 206425
TEVA-OLMESARTAN / HCTZ 12.5MG 40MG TABLET Resolved 2018-09-12 2020-06-11 61359
TEVA-CILAZAPRIL/HCTZ 12.5MG 5MG TABLET Resolved 2019-06-18 2019-08-06 86975
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2017-04-03 2017-09-19 5229
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-04-27 67234
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-07-15 67237
TEVA-TELMISARTAN HCTZ 12.5MG 80MG TABLET Resolved 2018-11-20 2019-04-27 67240

Showing 701 to 720 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917

Showing 21 to 40 of 250